Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.
Discov Oncol
; 13(1): 140, 2022 Dec 15.
Article
en En
| MEDLINE
| ID: mdl-36522513
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Discov Oncol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania